Ph.D. David W. Osborne - 08 Jul 2022 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Signature
/s/ Scott Burrows, as Attorney-in-Fact for David W. Osborne, Ph.D.
Issuer symbol
ARQT
Transactions as of
08 Jul 2022
Net transactions value
-$55,835
Form type
4
Filing time
12 Jul 2022, 19:30:56 UTC
Previous filing
21 Apr 2022
Next filing
02 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Sale $55,835 -2,197 -0.85% $25.41 256,649 08 Jul 2022 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $25.00 to $25.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Includes 24,925 RSUs.
F4 Reflects the adjusted total which includes the purchase of 1,617 shares under the Arcutis Employee Stock Purchase Plan on May 31, 2022.